tiprankstipranks
Virax Biolabs Group Ltd. Class A (VRAX)
:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Income Statement

Compare
104 Followers

Virax Biolabs Group Ltd. Class A Income Statement

Last quarter (Q4 2024), Virax Biolabs Group Ltd. Class A's total revenue was $79.92K, a decrease of -186.06% from the same quarter last year. In Q4, Virax Biolabs Group Ltd. Class A's net income was $-3.82M. See Virax Biolabs Group Ltd. Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 156.42K-$ 0.00$ 123.82K$ 99.88K
Gross Profit
$ 50.59K-$ 0.00$ -9.43K$ 45.75K
Operating Expenses
$ 6.55M$ 5.73M$ 1.73M$ 635.10K$ 696.99K
Depreciation and Amortization
$ 103.10K$ 1.00$ 1.73M$ 644.54K$ 651.24K
EBITDA
$ -6.61M$ -5.44M$ -750.00$ 0.00$ -648.77K
Operating Income
$ -6.50M$ -5.73M$ -1.73M$ -644.54K$ -651.24K
Other Income/Expenses
$ -242.65K$ 275.00K$ -16.19K$ -28.38K$ -88.22K
Pretax Income
$ -6.74M$ -5.46M$ -1.75M$ -672.91K$ -739.46K
Net Income
$ -6.73M$ -5.46M$ -1.71M$ -650.98K$ -801.13K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.36$ -5.13$ -1.50$ -0.57$ -0.70
Diluted EPS
$ -3.36$ -5.13$ -1.50$ -0.57$ -0.70
Weighted Average Shares Outstanding
2.01M 1.06M 1.14M 1.14M 1.14M
Weighted Average Shares Outstanding (Diluted)
2.01M 1.06M 1.14M 1.14M 1.14M
Currency in USD

Virax Biolabs Group Ltd. Class A Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis